➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Johnson and Johnson
Baxter
Express Scripts
Moodys

Last Updated: October 20, 2020

DrugPatentWatch Database Preview

EXEMESTANE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for exemestane and what is the scope of freedom to operate?

Exemestane is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn, Alvogen, Amneal Pharms, Breckenridge, Cipla, Hikma, Mayne Pharma Inc, Mylan, Qilu, Upsher Smith Labs, and Zydus Pharms, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for exemestane. Thirteen suppliers are listed for this compound.

Drug Prices for EXEMESTANE

See drug prices for EXEMESTANE

Recent Clinical Trials for EXEMESTANE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
First Affiliated Hospital, Sun Yat-Sen UniversityPhase 2
Fudan UniversityPhase 2
Istituto Di Ricerche Farmacologiche Mario NegriPhase 3

See all EXEMESTANE clinical trials

Pharmacology for EXEMESTANE
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors

US Patents and Regulatory Information for EXEMESTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms EXEMESTANE exemestane TABLET;ORAL 206421-001 Dec 28, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
Alvogen EXEMESTANE exemestane TABLET;ORAL 200898-001 Jul 28, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma EXEMESTANE exemestane TABLET;ORAL 077431-001 Apr 1, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Mayne Pharma Inc EXEMESTANE exemestane TABLET;ORAL 208764-001 Aug 8, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
Johnson and Johnson
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.